OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-AH68         View EO 12866 Meetings	Received Date: 10/04/2022
Title: Medication Guide; Patient Medication Information
Agency/Subagency: HHS / FDA	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 05/10/2023
Legal Deadline: None	Economically Significant: No
Publication Date: 05/31/2023	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Yes	Small Entities Affected: Businesses
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No